Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKD3 | O94806 | 1/20 | 0.44 |
| ▸ | PRKCG | P05129 | 1/20 | 0.44 |
| ▸ | PRKCB | P05771 | 1/20 | 0.44 |
| ▸ | PRKCA | P17252 | 1/20 | 0.44 |
| ▸ | PRKCH | P24723 | 1/20 | 0.44 |
| ▸ | PRKCI | P41743 | 1/20 | 0.44 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.44 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.44 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.44 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.44 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.39 |
| ▸ | CHRM5 | P08912 | 4/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.39 |
| ▸ | CHRM3 | P20309 | 4/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.39 |
| ▸ | CHRM4 | P08173 | 3/20 | 0.39 |
| ▸ | HTR1A | P08908 | 2/20 | 0.39 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12936646 | 0.97 | PRKD3 (0.42) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL345651 | 0.87 | CHRM5 (0.46) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL14029739 | 0.85 | PRKD3 (0.35) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL12560592 | 0.84 | CHRM5 (0.43) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| Hydrochloric Acid SCHEMBL9403409 | 0.84 | CHRM5 (0.48) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL3862570 | 0.83 | PRKD3 (0.55) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL14598546 | 0.83 | DNM1 (0.48) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| Iodide SCHEMBL30166462 | 0.81 | CHRM5 (0.42) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| Hydrochloric Acid SCHEMBL28136226 | 0.81 | CHRM5 (0.42) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL3768475 | 0.81 | PRKD3 (0.63) | PRKD3PRKCGPRKCBPRKCAPRKCH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119786714-A | High-conductivity high-migration-number lithium metal battery gel electrolyte, preparation method thereof and lithium battery | 武汉大学 | 2025-04-08 | — | — | CN | disclosed |
| US-20240215890-A1 | Bio-Electrode, Bio-Electrode Composition, And Method For Manufacturing Bio-Electrode | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-07-04 | — | — | US | disclosed |
| US-20240215891-A1 | Bio-Electrode Composition, Bio-Electrode, And Method For Manufacturing Bio-Electrode | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-07-04 | — | — | US | disclosed |
| US-11839700-B2 | Bio-electrode composition, bio-electrode, and method for manufacturing a bio-electrode | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-12-12 | — | — | US | disclosed |
| US-11783958-B2 | Conductive wiring material composition, conductive wiring substrate and method for producing conductive wiring substrate | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-10-10 | — | — | US | disclosed |
| US-11774853-B2 | Resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-10-03 | — | — | US | disclosed |
| US-11733608-B2 | Resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-08-22 | — | — | US | disclosed |
| US-11733608-B2 | Resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-08-22 | — | — | US | disclosed |
| US-11720018-B2 | Chemically amplified resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-08-08 | — | — | US | disclosed |
| US-20230152692-A1 | CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-05-18 | — | — | US | disclosed |
| EP-1960327-A2 | OLIGOMERISATION | The Queen's University of Belfast (GB) | 2008-08-27 | — | — | EP | disclosed |
| EP-1824805-A1 | METHOD FOR PREPARATION OF ORGANOFLUORO COMPOUNDS IN ALCOHOL SOLVENTS | Futurechem Co., Ltd. (KR) | 2007-08-29 | — | — | EP | disclosed |
| US-20070148604-A1 | Photothermographic material | FUJIFILM CORPORATION | 2007-06-28 | — | — | US | disclosed |
| WO-2007068910-A2 | OLIGOMERISATION | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2007-06-21 | — | — | WO | disclosed |
| US-20060186419-A1 | Light-emitting device | KABUSHIKI KAISHA TOSHIBA (JP) | 2006-08-24 | — | — | US | disclosed |
| WO-2006065038-A1 | METHOD FOR PREPARATION OF ORGANOFLUORO COMPOUNDS IN ALCOHOL SOLVENTS | FUTURECHEM CO., LTD. (KR) | 2006-06-22 | — | — | WO | disclosed |
| EP-0883600-B1 | CATIONIC DETERGENT COMPOUNDS | PROCTER & GAMBLE (US) | 2001-10-24 | — | — | EP | disclosed |
| EP-0883600-A1 | CATIONIC DETERGENT COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 1998-12-16 | — | — | EP | disclosed |
| WO-1997031889-A1 | CATIONIC DETERGENT COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 1997-09-04 | — | — | WO | disclosed |
| US-5602176-A | ENZYME INHIBITOR; LEARNING ENHANCEMENT; COGNITION ACTIVATORS | SANDOZ LTD. (CH) | 1997-02-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11733608-B2 | Resist composition and patterning process | HNRNPU, INSR, BICRA | PRKD3 4600/4885PRKCG 3553/4885PRKCB 3260/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.